19 research outputs found
Defining the course of neurosarcoidosis according to presentation at onset and disease modifying treatment: a cohort study of 84 patients
Background: Neurosarcoidosis is a rare manifestation of sarcoidosis with heterogeneous presentations. Patient management is challenging due to the current lack of knowledge about the long-term disease course. Objective: To identify specific disease courses of neurosarcoidosis according to the clinical and paraclinical presentations at onset. Methods: We conducted an observational multicenter cohort study by retrospectively collecting data from the medical records of 84 patients diagnosed with definite, probable, or possible neurosarcoidosis in three tertiary referral centers in France (Nancy, Strasbourg, and Bordeaux). We collected demographic characteristics, clinical and paraclinical data at the beginning of patient management, and during follow-up under the different treatment lines. Two expert neurologists determined disease course profiles. Results: The mean follow-up was 6.6âyears. Almost every patient (96.4%) received steroids at some point of their follow-up. Tumor Necrosis Factor-alpha blockers were given in 10.7% as first-line treatment and in 33.3% during follow-up. Every patient presented with a relapsing disease, often monophasic (75%) and sometimes polyphasic with the recurrence of identical manifestations (11.9%). Patients developing new neurological symptoms during follow-up were a minority (13.1%). No patients exhibited a progressive course. Patients with isolated cranial nerves injury or aseptic meningitis always exhibited a monophasic course, and 62.5â75% of them had a full recovery after first-line treatments. This proportion was 15.6% in other forms of the disease. Those with peripheral presentations were more likely to present a polyphasic course than patients with other forms of neurosarcoidosis. Spinal cord presentations were monophasic, but resulted in sequelae and exhibited poor response to first-line treatments despite frequent use of TNF-alpha blockers. Conclusion: Identification of these disease course profiles, based on the initial clinical and paraclinical presentation, could guide the clinician to select the optimal therapeutic approach and follow-up modalities for their patients with neurosarcoidosis
Differential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated Syndrome
International audienc
Longitudinal study of functional brain network reorganization in clinically isolated syndrome
International audienceBackground:There is a lack of longitudinal studies exploring the topological organization of functional brain networks at the early stages of multiple sclerosis (MS).Objective:This study aims to assess potential brain functional reorganization at rest in patients with CIS (PwCIS) after 1 year of evolution and to characterize the dynamics of functional brain networks at the early stage of the disease.Methods:We prospectively included 41 PwCIS and 19 matched healthy controls (HCs). They were scanned at baseline and after 1âyear. Using graph theory, topological metrics were calculated for each region. Hub disruption index was computed for each metric.Results:Hub disruption indexes of degree and betweenness centrality were negative at baseline in patients (pâ<â0.05), suggesting brain reorganization. After 1âyear, hub disruption indexes for degree and betweenness centrality were still negative (pâ<â0.00001), but such reorganization appeared more pronounced than at baseline. Different brain regions were driving these alterations. No global efficiency differences were observed between PwCIS and HCs either at baseline or at 1âyear.Conclusion:Dynamic changes in functional brain networks appear at the early stages of MS and are associated with the maintenance of normal global efficiency in the brain, suggesting a compensatory effect
Relationships between reorganization of functional brain network topology and cognition in clinically isolated syndrome: A 1 year Resting-state fMRI longitudinal study
International audienc
Relationships between reorganization of functional brain network topology and cognition in clinically isolated syndrome: A 1 year Resting-state fMRI longitudinal study
International audienc
Microstructural alterations precede subcortical deep grey matter volume loss in patients with clinically isolated syndrome
International audienc
Microstructural alterations precede subcortical deep grey matter volume loss in patients with clinically isolated syndrome
International audienc
First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study
International audienceFew data are available regarding patients with very late-onset inflammatory demyelinating events. (VLO-IDE).Objectives: The aim of this study was to describe the clinical, biological, and radiological characteristics and aetiological diagnosis of very late first inflammatory demyelinating events of the central nervous system.Methods: We conducted a national descriptive retrospective multicentre study on a case series of patients aged >70 years at the time of VLO-IDE. Patients were recruited from a national call on behalf of the 'Société Francophone de la Sclérose en Plaques' (French Multiple Sclerosis Society).Results: Twenty-five patients were referred (F:M sex ratio 2.1:1). The most frequent clinical impairment was a spinal cord deficit (23/25), usually severe (disability score, median EDSS 4.5 [2-9.5]). Spinal cord lesions were usually extensive, spanning at least three segments (11/25), and large brain lesions were also observed (lesions >20 mm in 6/25). The final aetiological diagnoses comprised multiple sclerosis (9/25), neuromyelitis optica spectrum disorders (7/25), neurosystemic lupus erythematosus (2/25), transverse myelitis without aetiological diagnosis (6/25) and optic neuritis (1/25).Conclusions: This study highlights a particular phenotype of first clinical inflammatory demyelinating events in predominantly female patients aged >70 years who have severe motor impairment with common longitudinal extensive myelitis and large and common very active radiological inflammatory lesions. Neuromyelitis optica spectrum disorders seem overrepresented
J Clin Apher
Introduction No randomized controlled clinical trial of therapeutic plasma exchanges (TPE) has yet been performed for moderateâtoâsevere relapses of multiple sclerosis (MS). Objective To compare TPE to shamâTPE in patients with a recent steroidâresistant moderateâtoâsevere MS relapse. Methods Patients presenting with an MS relapse of less than 2 months without improvement and 15âdays after a course of steroids were randomized. Specific criteria were used for each relapse type to define moderateâtoâsevere disability. The primary endpoint was the proportion of patients with at least a moderate improvement based on objective and functional evaluation after 1 month. Results Thirtyâeight patients were randomized. The intentionâtoâtreat analysis included 14 patients in the TPE group and 17 in the ShamâTPE group. The proportion of patients with at least moderate improvement at 1 month did not differ between the groups (P = .72), although 57.1% of the TPE group had full recovery compared with 17.6% of the sham group. Considering optic neuritis (ON), a significant difference in the proportion of different levels of improvement was observed in favor of the TPE group (P = .04). The combined Kurtzke's functional systems scores were significantly more improved in the TPE group than in the shamâTPE group at months 1 (Pâ<â.01), 3 (Pâ<â.05), and 6 (Pâ<â.05). No major side effects were observed. Conclusions A significant difference between TPE and ShamâTPE at the primary endpoint was only observed in patients with ON. Neurological function improved significantly more often in the TPE group than in the shamâTPE group